Christopher Brown is a seasoned professional in market access analytics and specialty pharmacy management, currently serving as Director of Market Access Analytics at Eisai US since December 2019. Brown has extensive experience in the pharmaceutical industry, having held key roles including Finance Business Partner for Oncology at Eisai US and Associate Director of Patient Access & Specialty Services at Novartis. Previous positions include leadership roles at EMD Serono, Bayer HealthCare, Sabert Corporation, and Accredo Health, where responsibilities encompassed strategy development, operational excellence, pricing analysis, vendor management, and driving commercial success across various therapeutic areas. Brown holds a BS in Finance & Management from Montclair State University.
This person is not in any teams
This person is not in any offices